Glucocorticoid-Induced Fatty Liver Disease
Leili Rahimi,1 Aman Rajpal,1,2 Faramarz Ismail-Beigi1,2 1Department of Medicine, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; 2Cleveland VA Medical Center, Cleveland, OH, USACorrespondence: Faramarz Ismail-BeigiDepartment of Medicine, Case Weste...
Main Authors: | Rahimi L, Rajpal A, Ismail-Beigi F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/glucocorticoid-induced-fatty-liver-disease-peer-reviewed-article-DMSO |
Similar Items
-
Role of Leptin in Non-Alcoholic Fatty Liver Disease
by: Carlos Jiménez-Cortegana, et al.
Published: (2021-06-01) -
Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy
by: Qianqian Yan, et al.
Published: (2022-10-01) -
Sex-Dependent Variations in Hypothalamic Fatty Acid Profile and Neuropeptides in Offspring Exposed to Maternal Obesity and High-Fat Diet
by: Mayara da Nóbrega Baqueiro, et al.
Published: (2024-01-01) -
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
by: Marta Flisiak-Jackiewicz, et al.
Published: (2021-03-01) -
Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart
by: Rui Shang, et al.
Published: (2021-07-01)